drugset / Trial / NCT00809042

Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia

NCT00809042

Phase 2 Completed 120 enrolled Shiraz University of Medical Sciences
RandomizedFactorialDouble-blindTreatment

Summary

The purpose of this study is determination of the efficacy of combination of hydroxyurea with L-carnitine or magnesium in improving hematologic parameters and cardiac status in patients with β-thalassemia intermedia in comparison with hydroxyurea alone .

Timeline

Start
2007-06
Primary completion
2007-11
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxyurea Other / unclassified 10 mg/kg
Comparator L-carnitine Other / unclassified 50 mg/kg
Comparator MAGNESIUM CHLORIDE ANHYDROUS Small molecule 0.6 unknown